Patents by Inventor JULIEN POTHLICHET

JULIEN POTHLICHET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AND THE USES THEREOF
    Publication number: 20220281959
    Abstract: The present invention relates to antibodies and their use. The invention particularly relates to antibodies against a particular domain of gp41, pharmaceutical compositions or kits or any device comprising the same, as well as the uses thereof. The invention is particularly useful for treating (e.g., curing or preventing), detecting or monitoring AIDS in a subject, either, alone or in combination with other treatments/agents.
    Type: Application
    Filed: August 26, 2020
    Publication date: September 8, 2022
    Inventors: JULIEN POTHLICHET, JACQUES THEZE
  • INHIBITORS OF PLA2-G1B COFACTORS FOR TREATING CANCER
    Publication number: 20200399392
    Abstract: The present invention relates to novel therapeutic approaches for treating cancer in mammals, particularly in human subjects, using an inhibitor of a PLA2-GIB cofactor.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 24, 2020
    Inventors: JULIEN POTHLICHET, PHILIPPE POULETTY, JACQUES THEZE
  • MODULATION OF PLA2-G1B IN THERAPY
    Publication number: 20200397855
    Abstract: The present invention relates to novel therapeutic approaches for treating or preventing diseases in mammals, particularly in human subjects, using a PLA2-GIB cofactor, or a modulator of a PLA2-GIB cofactor.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 24, 2020
    Inventors: JULIEN POTHLICHET, PHILIPPE POULETTY, JACQUES THEZE